These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20718816)

  • 1. A new class of human mast cell and peripheral blood basophil stabilizers that differentially control allergic mediator release.
    Norton SK; Dellinger A; Zhou Z; Lenk R; Macfarland D; Vonakis B; Conrad D; Kepley CL
    Clin Transl Sci; 2010 Aug; 3(4):158-69. PubMed ID: 20718816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fullerene nanomaterials inhibit the allergic response.
    Ryan JJ; Bateman HR; Stover A; Gomez G; Norton SK; Zhao W; Schwartz LB; Lenk R; Kepley CL
    J Immunol; 2007 Jul; 179(1):665-72. PubMed ID: 17579089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils.
    Zellweger F; Buschor P; Hobi G; Brigger D; Dahinden CA; Villiger PM; Eggel A
    Cell Death Dis; 2018 May; 9(5):510. PubMed ID: 29724998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food allergy herbal formula 2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils.
    Song Y; Qu C; Srivastava K; Yang N; Busse P; Zhao W; Li XM
    J Allergy Clin Immunol; 2010 Dec; 126(6):1208-17.e3. PubMed ID: 21134573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease.
    Gomez G
    Front Immunol; 2019; 10():175. PubMed ID: 30792720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically engineered negative signaling molecules in the immunomodulation of allergic diseases.
    Saxon A; Zhu D; Zhang K; Allen LC; Kepley CL
    Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):563-8. PubMed ID: 15640700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation.
    Abdala-Valencia H; Bryce PJ; Schleimer RP; Wechsler JB; Loffredo LF; Cook-Mills JM; Hsu CL; Berdnikovs S
    J Immunol; 2015 Aug; 195(4):1377-87. PubMed ID: 26136426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FcvarepsilonR1 signaling pathway.
    Oliver JM; Kepley CL; Ortega E; Wilson BS
    Immunopharmacology; 2000 Jul; 48(3):269-81. PubMed ID: 10960668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Hydroxy-3-methoxybenzoic acid attenuates mast cell-mediated allergic reaction in mice via modulation of the FcεRI signaling pathway.
    Kim YY; Je IG; Kim MJ; Kang BC; Choi YA; Baek MC; Lee B; Choi JK; Park HR; Shin TY; Lee S; Yoon SB; Lee SR; Khang D; Kim SH
    Acta Pharmacol Sin; 2017 Jan; 38(1):90-99. PubMed ID: 27890918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of IgE-mediated allergic reactions by pharmacologically targeting the circadian clock.
    Nakamura Y; Nakano N; Ishimaru K; Ando N; Katoh R; Suzuki-Inoue K; Koyanagki S; Ogawa H; Okumura K; Shibata S; Nakao A
    J Allergy Clin Immunol; 2016 Apr; 137(4):1226-1235. PubMed ID: 26559325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLAP Is a Negative Regulator of FcεRI Receptor-Mediated Signaling and Allergic Response.
    Sharma N; Ponce M; Kaul S; Pan Z; Berry DM; Eiwegger T; McGlade CJ
    Front Immunol; 2019; 10():1020. PubMed ID: 31156621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. News in Cellular Allergology: A Review of the Human Mast Cell and Basophil Granulocyte Literature from January 2013 to May 2015.
    Hoffmann HJ
    Int Arch Allergy Immunol; 2015; 168(4):253-62. PubMed ID: 26895271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the use of genetically engineered negative signaling molecules to treat allergic diseases.
    Saxon A; Zhu D; Zhang K; Chan LA; Kepley CL
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):223-31; discussion 231-3. PubMed ID: 17393744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propolis suppresses cytokine production in activated basophils and basophil-mediated skin and intestinal allergic inflammation in mice.
    Kashiwakura JI; Yoshihara M; Saitoh K; Kagohashi K; Sasaki Y; Kobayashi F; Inagaki I; Kitai Y; Muromoto R; Matsuda T
    Allergol Int; 2021 Jul; 70(3):360-367. PubMed ID: 33279402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of C5a-induced basophil degranulation by disodium cromoglycate.
    Golden HW; Iacuzio DA; Otterness IG
    Agents Actions; 1987 Aug; 21(3-4):371-4. PubMed ID: 2446479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A strain of Lactobacillus casei inhibits the effector phase of immune inflammation.
    Schiffer C; Lalanne AI; Cassard L; Mancardi DA; Malbec O; Bruhns P; Dif F; Daëron M
    J Immunol; 2011 Sep; 187(5):2646-55. PubMed ID: 21810608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels.
    Kepley CL
    Int Arch Allergy Immunol; 2005 Sep; 138(1):29-39. PubMed ID: 16088210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk.
    Lee JH; Kim JW; Ko NY; Mun SH; Her E; Kim BK; Han JW; Lee HY; Beaven MA; Kim YM; Choi WS
    J Allergy Clin Immunol; 2008 May; 121(5):1225-31. PubMed ID: 18394691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK1/2 antagonize AMPK-dependent regulation of FcεRI-mediated mast cell activation and anaphylaxis.
    Hwang SL; Lu Y; Li X; Kim YD; Cho YS; Jahng Y; Son JK; Lee YJ; Kang W; Taketomi Y; Murakami M; Moon TC; Chang HW
    J Allergy Clin Immunol; 2014 Sep; 134(3):714-721.e7. PubMed ID: 24948367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol inhibits IL-33-mediated mast cell activation by targeting the MK2/3-PI3K/Akt axis.
    Nakajima S; Ishimaru K; Kobayashi A; Yu G; Nakamura Y; Oh-Oka K; Suzuki-Inoue K; Kono K; Nakao A
    Sci Rep; 2019 Dec; 9(1):18423. PubMed ID: 31804564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.